AqueSys is developing a proprietary surgical device for the treatment of glaucoma. Glaucoma is the second leading cause of blindness worldwide and affects up to 65 million individuals.
AqueSys has raised A, B and C rounds of venture financing totaling $51 million.
9834 Research Drive
Irvine, CA 92618